IGF-1 Variants in Research: DES, LR3, and PEG-MGF Compared

Insulin-like Growth Factor 1 (IGF-1) is a fundamental growth factor in muscle and tissue research. However, native IGF-1 has limitations in research settings — it binds tightly to IGF-binding proteins (IGFBPs) which reduce its bioavailability, and it has a relatively short half-life. Three modified variants address these limitations in different ways.

IGF-1 DES (Des 1-3)

IGF-1 DES is a truncated variant of IGF-1 with the first three N-terminal amino acids (Gly-Pro-Glu) removed. This truncation has a significant effect:

• Reduced IGFBP binding — The des(1-3) truncation dramatically reduces binding to IGF-binding proteins, particularly IGFBP-3, the most abundant binding protein in circulation.
• Increased receptor potency — With less binding protein sequestration, more of the peptide is available to activate the IGF-1 receptor, resulting in increased potency in research models.
• Shorter half-life — Without binding protein protection, IGF-1 DES has a shorter half-life than native IGF-1, making it suitable for studying acute IGF-1 receptor activation.

IGF-1 LR3 (Long R3)

IGF-1 LR3 takes a different approach to reducing IGFBP binding:

• Arginine substitution — An arginine replaces glutamic acid at position 3 (R3), reducing IGFBP affinity.
• Extended N-terminus — A 13-amino acid extension is added at the N-terminus (Long), further reducing binding protein interaction and extending half-life.
• Sustained receptor activation — The combined modifications produce a longer-acting IGF-1 receptor agonist, suitable for studying sustained IGF-1 signalling.

PEG-MGF (PEGylated Mechano Growth Factor)

PEG-MGF is distinct from IGF-1 DES and LR3 — it is a splice variant of IGF-1 rather than a modified full-length analogue:

• Mechano Growth Factor — MGF is produced in response to mechanical stress on muscle tissue and is studied for its role in satellite cell activation and muscle repair.
• PEGylation — The PEG (polyethylene glycol) group extends the peptide's half-life, making it more suitable for sustained-release research.
• Satellite cell focus — While IGF-1 DES and LR3 primarily study IGF-1 receptor signalling, PEG-MGF is specifically studied for its effects on satellite cell activation and muscle tissue repair signalling.

Choosing the Right Variant

Researchers choose between these three variants based on their research goals:

Variant	Key Feature	Research Application
IGF-1 DES	High potency, short half-life	Acute IGF-1 receptor activation studies
IGF-1 LR3	Extended half-life, sustained signalling	Long-term IGF-1 pathway research
PEG-MGF	Satellite cell activation	Muscle repair and regeneration research

The IGF-1 Receptor Pathway

All three variants act on the IGF-1 receptor (a receptor tyrosine kinase), activating downstream signalling through the PI3K/Akt and MAPK/ERK pathways. These pathways are fundamental to cell proliferation, differentiation, and survival signalling in research models.

Purity and Verification

All IGF-1 variants from HPLC Peps are independently tested by Janoshik at 99%+ HPLC purity with published Certificates of Analysis. Researchers from London to Aberdeen, Liverpool to Cardiff, and across the UK trust HPLC Peps as their peptide supplier UK for the highest purity growth factor research compounds.

Coming Soon

IGF-1 DES, IGF-1 LR3, and PEG-MGF are all part of our Coming Soon range. Sign up for stock notifications on each product page to be notified when these compounds become available.

---

For laboratory research use only. Not for human consumption, medical diagnosis, or treatment.